SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?
Severe Acute Respiratory Syndrome coronavirus-2 has rapidly spread and emerged as a pandemic. Although evidence on its pathophysiology is growing, there are still issues that should be taken into consideration, including its effects on pre-existing peripheral vascular disease. The aim of this review...
Main Authors: | Grigorios Voulalas, Janice Tsui, Luciano Candilio, Daryll Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | https://doi.org/10.1177/11795468211010705 |
Similar Items
-
SARS-CoV-2 in pre-existing autoimmune myasthenia gravis: An institutional experience
by: Nitisha Goyal, et al.
Published: (2021-03-01) -
Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
by: Amandine Mveang Nzoghe, et al.
Published: (2021-03-01) -
Specific Treatment Exists for SARS-CoV-2 ARDS
by: Badar Kanwar, et al.
Published: (2021-06-01) -
Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01) -
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)